Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Benecchi Christopher Create: Alert

All | News | Filings
Date FiledTypeDescription
02/07/2023 4 Benecchi Christopher (Chief Business Officer) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 6,750 shares @ $0
Paid exercise price by delivering 2,119 shares @ $44.16, valued at $93.6k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Benecchi Christopher (Chief Commercial Officer) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 11,400 options to buy @ $43.04, valued at $490.7k
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy